Global Organ Preservation Techniques Market Strategic Research Report

Organ preservation techniques encompass the solutions, devices, and machine perfusion systems used to maintain donor organ viability between procurement and transplantation, spanning traditional static cold storage using specialized preservation solutions and increasingly sophisticated machine perfusion technology (hypothermic and normothermic) that actively perfuses organs with oxygenated preservation media, extending viable preservation time and improving post-transplant organ function outcomes relative to static cold storage alone. The shift toward machine perfusion represents one of the most significant recent advances in transplant medicine, directly addressing organ shortage challenges by expanding the pool of usable donor organs.

Growth is driven by persistent global organ transplant waitlist growth outpacing donor organ availability, creating strong clinical and economic incentive to adopt technologies that expand usable organ supply, alongside machine perfusion's demonstrated ability to rehabilitate marginal or extended-criteria donor organs (previously considered too high-risk for transplantation) into viable transplant candidates. A secondary driver is growing clinical evidence supporting normothermic machine perfusion's superior preservation outcomes for liver and kidney transplantation specifically, driving expanding adoption across major transplant centers. The primary restraint is the substantial capital cost of machine perfusion systems relative to traditional static cold storage, which limits adoption to well-resourced transplant centers, alongside the logistical complexity of machine perfusion systems relative to simpler static storage for organ transport scenarios.

This report covers the global organ preservation techniques market by preservation method, organ type, and region, along with competitive profiles of leading organ preservation technology companies. It is intended for transplant center procurement and clinical teams, organ preservation technology developers, and healthcare/medtech industry investors.